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Summary
 
The ability of influenza A virus-specific cytotoxic T lymphocytes (CTL) to
degranulate and produce cytokines upon antigenic restimulation was studied
in four HLA-A*0101 and HLA-A*0201 positive subjects. Peripheral blood
mononuclear cells of these subjects were stimulated with influenza A virus in
the presence of high or low interleukin (IL)-2 concentrations. CD8
 
+
 
 T cell
populations specific for the HLA-A*0101 restricted epitope NP
 
44-52
 
 and the
HLA-A*0201 restricted epitope M1
 
58-66
 
 were identified by positive staining
with  tetramers  of  peptide  major  histocompatibility  complexes  (MHC)
(NP-Tm and M1-Tm, respectively). Within these populations, the proportion
of cells mobilizing CD107a, or expressing interferon (IFN)-g
 
 and tumour
necrosis factor-(TNF)-a
 
 upon short-term peptide restimulation was deter-
mined by flow cytometry. Independent of IL-2 concentrations, large subject-
dependent differences in the mobilization of CD107a and expression of
IFN-g
 
 and TNF-a
 
 by both NP- and M1-specific T cells were observed. In two
of the four subjects, the functional profile of NP-Tm
 
+
 
 and M1-Tm
 
+
 
 cells dif-
fered considerably. Overall, no difference in the proportion of NP-Tm
 
+
 
 or M1-
Tm
 
+
 
 cells expressing CD107a was observed. The proportion of M1-Tm
 
+
 
 cells
that produced IFN-g
 
 (
 
P 
 
< 0·05) was larger than for NP-Tm
 
+
 
 cells, independent
of IL-2 concentration. When cultured under IL-2
 
hi
 
 concentrations higher
TNF-a
 
 expression was also observed in M1-Tm
 
+
 
 cells (
 
P 
 
< 0·05). The IL-2 con-
centration during expansion of virus-specific cells had a profound effect on
the functionality of both M1-Tm
 
+
 
 and NP-Tm
 
+
 
 cells.
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Introduction
 
Cytotoxic T lymphocytes (CTL) play an important role in
the control of virus infections, including those caused by
influenza viruses [1,2]. Important effector cell functions
include the killing of virus-infected cells through the excre-
tion of perforin and granzyme molecules or induction of
apoptosis through Fas/FasL signalling, and the production of
cytokines such as interferon (IFN)-
 
g
 
 and tumour necrosis
factor (TNF)-
 
a
 
 [3].
Recent research has identified differential expression of
CD45R isoforms, CCR7, CD62L, CD27, CXCR4 and CD28
on functionally different CD8
 
+
 
 T cell populations [4–12],
which have been associated with consecutive stages of
human CD8
 
+
 
 T cell development during and after acute viral
infections. Upon infection naive, effector and memory cells,
each with their own characteristics regarding cytokine pro-
duction, proliferation and effector function, were discrimi-
nated. Peptide-HLA class I tetramers (Tm) have also been
used to study CTL populations specific for distinct viral
epitopes from various viruses (human immunodeficiency
virus (HIV), cytomegalovirus (CMV), Epstein–Barr virus
(EBV), hepatitis C virus and influenza A virus [13–17], dem-
onstrating differences in perforin and granzyme expression,
lytic capacity, cytokine production and cell surface molecule
expression between the different epitope-specific CTL
populations. In mice, CTL specific for the F- or G-protein
of respiratory syncitial  virus (RSV) produced less IFN-
 
g
 
than CTL specific for an epitope of influenza A virus [18].
It is unknown, however, whether these functional and
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phenotypical differences in CTL are the result of different
virus aetiologies or epitope/HLA-specificities or both. Lim-
ited data are available on functional heterogeneity in CTL
populations specific for various epitopes from a single virus
[16,19–22]. Differences in cell surface marker expression
and/or cytokine production in human CTL specific for dif-
ferent EBV epitopes and mouse CTL specific for two differ-
ent influenza virus epitopes have been reported [20,22]. We
also demonstrated differences in cytokine expression profiles
for influenza virus-specific CTL restricted by different HLA
class I molecules. CTL specific for HLA-A1 restricted
epitopes produced more TNF-
 
a
 
 than IFN-
 
g
 
, while HLA-B8,
-B35 and -A2 restricted epitope-specific CTL produced
mainly IFN-
 
g
 
 and to a lesser extent TNF-
 
a
 
 [23].
The roles of microenvironment, T cell receptor (TCR)
avidity, peptide concentration, and co-receptor dependence
in defining CTL effector functions are still largely unclear.
Some studies have demonstrated a positive relationship
between TCR avidity and functional profiles of epitope-
specific CTL [24], while other studies dispute this relation-
ship and suggest other factors involved in determining the
functional profile of CTL [25]. Cytokines such as IL-2 may
also be important, as it was shown in mice that the addition
of exogenous IL-2 resulted in higher TNF-
 
a
 
 expression in
CTL [26].
Here the functional profile of polyclonal human CTL
populations specific for two different influenza A virus CTL
epitopes was investigated in multiple HLA-A*0101/A*0201
positive subjects. In addition, the influence of IL-2 concen-
tration during the 
 
in vitro
 
 expansion of these cells on the
lytic activity and cytokine expression in these CTL was
assessed.
 
Materials and methods
 
Cells, virus, peptides and tetramers
 
Four healthy blood donors, between 35 and 50 years of age,
were selected according to genetic homology within the A-
locus of human leucocyte antigen (HLA) class I molecules
and their CTL response to epitopes NP
 
44
 
-
 
52
 
 and M1
 
58
 
-
 
66
 
[23,27]. Genetic subtyping was performed using a commer-
cial typing system (Genovision, Vienna, Austria). Peripheral
blood mononuclear cells (PBMC) were isolated from whole
blood by Lymphoprep™ (Nycomed, Oslo, Norway) density
gradient centrifugation and cryopreserved at 
 
-
 
135
 
∞
 
C.
Sucrose gradient purified influenza A virus (H3N2)
Resvir-9, a reassortant between influenza virus A/Nanchang/
933/95 and A/Puerto Rico/8/34, was used for the infection of
PBMC. The virus contains both the HLA-A*0101-restricted
epitope NP
 
44
 
-
 
52
 
 (CTELKLSDY) and the HLA-A*0201-
restricted epitope M1
 
58
 
-
 
66
 
 (GILGFVFTL).
Synthetic peptides representing the epitope NP
 
44
 
-
 
52
 
 and
the epitope M1
 
58
 
-
 
66
 
 were manufactured, high profile liquid
chromatography (HPLC) purified and analysed by mass
spectometry (Eurogentec, Seraing, Belgium). Peptides were
dissolved in dimethyl sulphoxide (DMSO) (5·0 mg/ml),
diluted in RPMI-1640 medium (Cambrex, East Rutherford,
NJ, USA) to 100 
 
m
 
M
 
 and stored at 
 
-
 
20
 
∞
 
C until further use.
HLA-A*0101 and HLA-A*0201 molecules were com-
plexed with the NP
 
44
 
-
 
52
 
 and M1
 
58
 
-
 
66
 
 peptide, respectively, as
described previously [28]. Both HLA-A peptide complexes
were enzymatically biotinylated, fast protein liquid chroma-
tography (FPLC) purified and tetramerized by addition
of phycoerythrin (PE)-conjugated streptavidin (Sanquin
Research at CLB, Amsterdam, the Netherlands). The NP
 
44
 
-
 
52
 
peptide containing HLA-A*0101 tetramers are referred to as
NP-Tm, while the M1
 
5–-66
 
 peptide containing HLA-A*0201
tetramers are referred to as M1-Tm.
 
In vitro
 
 stimulation of PBMC with influenza A virus
 
Stimulation of PBMC with influenza A virus was performed
as described previously [27]. Cells were resuspended at 10
 
6
 
cells/ml in RPMI-1640 medium supplemented with 10%
fetal calf serum (FCS) (Greiner Bio-one, Alphen a/d Rijn, the
Netherlands), 2 m
 
M l
 
-glutamine, 100 
 
m
 
g/ml streptomycin
and 100 IU/ml penicillin (Cambrex, East Rutherford, NJ,
USA) (R10F) and infected with Resvir-9 at a multiplicity of
infection of 3. After 1 h at 37
 
∞
 
C, the cells were washed once
and resuspended in RPMI-1640 medium supplemented with
10% pooled human AB serum, 2 m
 
M l
 
-glutamine, 100 
 
m
 
g/
ml streptomycin, 100 IU/ml penicillin and 20 
 
m
 
M
 
 2-ME
(R10H), and added to uninfected PBMC at a ratio of 1 : 1 in
a 25-cm
 
2
 
 culture flask. After 2 days, 2 U/ml (IL-2
 
lo
 
) or 50 U/
ml (IL-2
 
hi
 
) rhIL-2 (Chiron BV Amsterdam, the Netherlands)
was added and the cells were incubated for another 6 days at
37
 
∞
 
C.
 
CD107a mobilization assay
 
Degranulation by CTL was assessed by mobilization of
CD107  [29,30].  Two  hundred  thousand  influenza  A
virus-stimulated PBMC were incubated in R10F containing
Golgistop™ (Monensin) (Becton Dickinson, Alphen a/d
Rijn, the Netherlands), in the presence or absence of 10 
 
m
 
M
 
synthetic peptide for 5 h at 37
 
∞
 
C. During the 5 h incubation,
fluorescein isothiocynate (FITC)-conjugated mouse-
antihuman CD107a monoclonal antibody (mAb) (clone
H4A3, Becton Dickinson) was added to each well. Next the
cells were washed once in phosphate buffered saline (PBS)
containing Golgistop and 2% FCS and incubated with NP-
Tm or M1-Tm. After 20 min at 20
 
∞
 
C, peridinin chlorophyll
protein (PerCP)-conjugated mouse-antihuman CD3 mAb
(clone SK7, Becton Dickinson) and allophycocyanin (APC)-
conjugated mouse-antihuman CD8 mAb (clone DK25,
Dako Cytomation, Glostrup, Denmark) were added for
10 min at 4
 
∞
 
C. Following one washing step, the cells were
acquired and analysed using a FACSCalibur (Becton Dickin-
son) flow cytometer in combination with CellQuest Pro soft-
ware (Becton Dickinson). The specific percentage CD107a
 
+
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cells of the NP-Tm
 
+
 
 or M1-Tm
 
+
 
 population was calculated
using the following formula:
% CD107a
 
+
 
 cells
 
(peptide stimulated)
 
 – % CD107a
 
+
 
 cells
 
(unstimulated)
 
.
 
Intracellular cytokine staining
 
IFN-
 
g
 
 and TNF-
 
a
 
 expression by influenza A virus-specific
CTL was determined using intracellular cytokine staining
as described previously [23,31]. Four hundred thousand
PBMC were incubated in 200 
 
m
 
l R10F containing Golgis-
top
 
TM
 
 or Golgiplug™ for the IFN-
 
g
 
 staining or TNF-
 
a
 
 stain-
ing, respectively, according to recommendations of the
manufacturer. Restimulation of NP
 
44
 
-
 
52
 
-specific and M1
 
58
 
-
 
66
 
-
specific effector cells was achieved by adding synthetic pep-
tides to the wells at a concentration of 10 
 
m
 
M
 
. Following 6 h
incubation at 37
 
∞
 
C, the cells were washed once in PBS with
2% FCS and incubated with NP-Tm and M1-Tm complexes.
After 20 min at 20
 
∞
 
C, FITC-conjugated mouse-antihuman
CD8 mAb (clone DK25, Dako Cytomation) and PerCP-
conjugated mouse-antihuman CD3 mAb were added for
10 min  at  4
 
∞
 
C.  Following  two  washing  steps,  the  cells
were fixed (Cytofix
 
TM
 
, Becton Dickinson), permeabilized
(Cytoperm
 
TM
 
, Becton Dickinson) and incubated with APC-
conjugated mouse-antihuman IFN-
 
g
 
 mAb (clone 4S.B3,
Becton Dickinson) or APC-conjugated mouse-anti-human
TNF-
 
a
 
 mAb (clone 6401·1111, Becton Dickinson) for
30 min at 4
 
∞
 
C. Next the cells were washed once in PBS with
2% FCS and subsequently acquired and analysed using a
FACSCalibur (Becton Dickinson) flow cytometer in com-
bination with CellQuest Pro software (Becton Dickinson).
At least 50 000 events were acquired. The specific per-
centage IFN-
 
g
 
 or TNF-
 
a
 
+
 
 cells of the NP-Tm
 
+
 
 or M1-Tm
 
+
 
population was calculated using the following formula: %
IFN-
 
g
 
+
 
 or TNF-
 
a
 
+
 
 cells
 
(peptide stimulated)
 
 –% IFN-
 
g
 
+
 
 or TNF-
 
a
 
+
 
cells
 
(unstimulated)
 
.
 
Statistical analysis
 
Mann–Whitney 
 
U
 
-test was applied to determine statistical
significance between NP-Tm
 
+
 
 or M1-Tm
 
+
 
 cells of all four
subjects or between IL-2lo or IL-2hi concentrations, using the
average frequency of responding cells measured in two or
three independently repeated assays. Significant differences
within a single subject were determined by comparing the
frequencies of both assays. A P-value below 0·05 was consid-
ered significant.
Results
No effect of IL-2 on proportion of NP-Tm+ and 
M1-Tm+ cells
CTL effector cell function was studied in two populations
specific for two influenza A virus CTL epitopes following in
vitro expansion of virus-specific T cells in the presence of 2
or 50 IU/ml IL-2. The frequency of NP-Tm+ and M1-Tm+
cells ranged from 4·5% to 15·3% in the CD3+, CD8+ T cell
fraction. In subjects 1, 2 and 4 the frequency of NP-Tm+ and
M1-Tm+ cells was similar, while in subject 3 the frequency of
M1-Tm+ cells was 1·5-fold higher than that the frequency of
NP-Tm+ cells (Fig. 1). The IL-2 concentration had no effect
on the proportion of Tm+ cells in the in vitro expanded virus-
specific T cell populations (Fig. 1).
A 1·34-fold increase in cell number was observed follow-
ing 8 days culture under high IL-2 (IL-2hi) conditions. Cul-
turing cells in low IL-2 (IL-2lo) concentrations resulted in a
1·05-fold increase in total cell number on day 8 (difference
not statistically significant).
CD107a mobilization on NP-Tm+ and M1-Tm+ cells
The ability of NP-Tm+ and M1-Tm+ effector cells to degran-
ulate upon antigenic stimulation was determined by measur-
ing the percentage of Tm+ cells expressing CD107a on their
surface after antigenic restimulation. An example of such an
analysis is shown in Fig. 2a–h. Unstimulated polyclonal
effector cells specific for NP44-52 and the M158-66 epitopes did
not mobilize CD107a. However, after stimulation with the
corresponding peptides, expression of CD107a was readily
detected in NP-Tm and M1-Tm positive cells. The magni-
tude of CD107a expression was dependent on the IL-2
concentration added during the expansion of virus-specific
CTL. This analysis was performed for all four study subjects
(Fig. 2i).
Under IL-2lo conditions, the portion of NP-Tm
+ and M1-
Tm+ cells expressing CD107a upon restimulation varied
Fig. 1. Proportion of tetramer positive cells in influenza A virus stim-
ulated peripheral blood mononuclear cells cultured under low or high 
interleukin (IL)-2 conditions.  Peripheral blood mononuclear cells of 
four HLA-A*0101 and HLA-A*0201 + subjects were stimulated with 
influenza A virus for 8 days, in the presence of low (white bars) or high 
(black bars) IL-2 concentrations. The percentage NP-Tm+ (a) and 
M1-Tm+ (b) cells was determined in the CD8+ CD3+ cell fraction as 
described in the Materials and methods section. Presented are the aver-
age percentage Tm+ cells, plus the standard deviation, of four indepen-
dently repeated assays.
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between 33% and 63% in the four subjects (Fig. 2), demon-
strating large subject-dependent differences. The average
percentage CD107a+ cells was similar between NP-Tm+
(54%) and M1-Tm+ (56%) cells. In some individuals, how-
ever, the CD107a expression on the surface of NP-Tm+ and
M1-Tm+ cells differed considerably. In subject 1 (squares;
Fig. 2i) the CD107a expression on NP-Tm+ cells (average of
67%) was significantly higher (P = 0·05) than the CD107a
expression on M1-Tm+ cells (average of 43%), while in sub-
ject 2 (circles; Fig. 2i), the proportion of NP-Tm+ cells (aver-
age 37%) expressing CD107a was lower than that of M1-Tm+
cells (average 61%) (P = 0·121). In the remaining two sub-
jects, no difference (< 10%) in the portion of CD107a+ cells
upon peptide restimulation was measured.
Next, we analysed if higher concentrations of IL-2 (IL-2hi),
added during the 8-day culture period, had an effect on the
capacity of Tm+ cells to express CD107a on their surface
upon peptide restimulation. In contrast to Tm+ cells cultured
under IL-2lo conditions, CD107a expression on NP-Tm
+ and
M1-Tm+ cells of individual subjects did not differ signifi-
cantly. However, the proportion of Tm+ cells expressing
CD107a following culture under IL-2hi conditions was sig-
nificantly higher (75% versus 55%; P < 0·01) than following
culture under IL-2lo conditions. The same was the case for
NP-Tm+ cells (72% versus 54%; P < 0·05) and M1-Tm+ cells
(78% versus 67%; P < 0·05).
IFN-g production by NP-Tm+ and M1-Tm+ cells
The ability of NP-Tm+ and M1-Tm+ cells from individual
study subjects to produce IFN-g was determined. Eight-day-
old effector cells, cultured under IL-2lo or IL-2hi conditions,
were restimulated for 6 h with peptides to initiate IFN-g
production. As shown in Fig. 3a–d for subject 2, IFN-g pro-
duction was induced in a proportion of the NP-Tm+ and M1-
Tm+ cells after stimulation with peptide loaded stimulator
cells.
In the four study subjects, IFN-g was produced in 55%
(range 33–65%) of the NP-Tm+  cells  cultured in low IL-2
(IL-2lo) concentrations (Fig. 3e). In M1-Tm
+ cells this per-
centage was 73% (range 66–80%), which is significantly
higher than the percentage IFN-g+ cells in the NP-Tm+ frac-
tion (P < 0·05, Fig. 3).
A larger proportion of NP-Tm+ and M1-Tm+ cells cultured
under IL-2hi conditions produced IFN-g upon restimulation.
On average 73·5% of the NP-Tm+ cells (range 56–82%) pro-
duced IFN-g, while in M1-Tm+ cells the average percentage
was 85% (range 79–90%) (Fig. 3e). This difference in IFN-g
expression by both Tm+ cell populations was significantly
different (P < 0·05, Fig. 3). The largest difference in propor-
tion of IFN-g+ cells between NP-Tm+ (average 56%) and M1-
Tm+ (average 90%) cells was found in subject 2.
Finally,  IFN-g  production by Tm+  cells  cultured under
IL-2hi and IL-2lo conditions was compared. Of the Tm
+ cells
cultured under IL-2hi conditions 80% produced IFN-g upon
peptide stimulation, while only 64% of the Tm+ cells, cul-
tured under IL-2lo conditions were IFN-g+. This difference in
IFN-g production between both IL-2 conditions was
statistically significant for M1-Tm+ cells and all Tm+ cells
(P < 0·05).
TNF-a production by NP-Tm+ and M1-Tm+ cells
In addition to IFN-g, the production of a second proinflam-
matory cytokine, TNF-a, was investigated. The TNF-a
expression by NP-Tm+ and M1-Tm+ cells of subject 2 is
shown in Fig. 4a–d. After expansion under IL-2lo conditions
26% of the NP-Tm+ cells and 46% of the M1-Tm+ cells pro-
duced TNF-a upon restimulation (Fig. 4e). After expansion
under IL-2hi conditions, these numbers increased. On
Fig. 2. CD107a staining on NP- and M1-Tm+ cells cultured under low 
or high interleukin (IL)-2 conditions. Peripheral blood mononuclear 
cells of four HLA-A*0101 and HLA-A*0201+ subjects were stimulated 
with influenza A virus for 8 days, in the presence of low (IL-2lo) or high 
(IL-2hi) IL-2 concentrations. CD107a surface expression on NP-Tm
+ and 
M1-Tm+ cells was determined after 5 h stimulation with cognate pep-
tides. An example of CD107a surface expression is shown on NP-Tm+ 
cells (a, b, e, f) and M1-Tm+ cells (c, d, g, h) cultured in IL-2lo (aÆd) 
and IL-2hi (eÆh) of subject 2. In (i), the average percentage CD107a+ 
cells of the NP-Tm+ and M1-Tm+ cells are shown for all four subjects. 
Subject 1 () subject 2 (), subject 3 (), subject 4 (). The indicated 
values in graphs (a–h) represent a single experiment, while graph (i) 
combines data of three independently repeated experiments.
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average 48% of the NP-Tm+ cells produced TNF-a, which
was significantly (P < 0·05) lower than the average percent-
age of TNF-a+ M1-Tm+ cells (67%) (Fig. 4).
Overall, the proportion of Tm+ cells producing TNF-a was
higher after expansion under IL-2hi conditions than after
expansion under IL-2lo conditions (Fig. 4e). These differ-
ences were statistically significant for M1-Tm+ and all Tm+
cells (P < 0·05) but not for NP-Tm+ cells (P = 0·083).
Discussion
The functional properties of polyclonal CTL populations
specific for two influenza A virus epitopes were studied in
four HLA-A*0101, HLA-A*0201 positive study subjects
using a combination of tetramer-staining and cell-surface
CD107a or intracellular cytokine staining. Epitope-
dependent as well as subject-dependent differences in the
expression of these effector cell molecules were identified.
Fig. 3. Intracellular interferon (IFN)-g staining of NP-Tm+ and M1-
Tm+ cells cultured under low or high interleukin (IL)-2 conditions. 
Peripheral blood mononuclear cells of four HLA-A*0101 and HLA-
A*0201+ subjects were stimulated with influenza A virus for 8 days, in 
the presence of low (IL-2lo) or high (IL-2hi) IL-2 concentrations. Intra-
cellular IFN-g staining was performed as described in Materials and 
methods following peptide restimulation of NP-Tm+ and M1-Tm+ cells. 
IFN-g staining in NP-Tm+ cells (a and c) and M1-Tm+ cells (b and d) 
cultured in IL-2lo (a and b) and IL-2hi (c and d) of subject 2 are shown 
as an example. In (e), the percentage IFN-g+ cells of the NP-Tm+ and 
M1-Tm+ cells are presented for all four subjects. Subject 1 () subject 
2 (), subject 3 (), subject 4 (). The indicated values in graphs 
(a–d) represent a single experiment, while graph (e) combines data of 
two independently repeated experiments.
%
 IF
N-
g+
0
80
60
40
20
NP-Tm M1-Tm
IL-2lo IL-2hi IL-2lo IL-2hi
M1-Tm
IF
N
-g
M1-Tm
NP-Tm
NP-Tm
(a) (b)
(c) (d)
23·9% 58·0%
48·5% 89·1%
IF
N
-g
IL-2lo
IL-2hi
-----
-----
-----
-----
(e)
100 101 102 103 1041
00
10
1
10
2
10
3
10
4
100 101 102 103 1041
00
10
1
10
2
10
3
10
4
100 101 102 103 1041
00
10
1
10
2
10
3
10
4
100 101 102 103 1041
00
10
1
10
2
10
3
10
4
Fig. 4. Intracellular tumour necrosis factor (TNF)-a staining of NP-
Tm+ and M1-Tm+ cells cultured under low or high interleukin (IL)-2 
conditions. Peripheral blood mononuclear cells of four HLA-A*0101 
and HLA-A*0201+ subjects were stimulated with influenza A virus for 8 
days, in the presence of low (IL-2lo) or high (IL-2hi) IL-2 concentrations. 
Intracellular TNF-a staining was performed as described in Materials 
and methods, following peptide restimulation of NP-Tm+ and M1-Tm+ 
cells. TNF-a staining in NP-Tm+ cells (a and c) and M1-Tm+ cells (b and 
d) cultured in IL-2lo (a and b) and IL-2hi (c and d) of subject 2 are shown 
as an example. In (e), the percentages TNF-a+ cells of the NP-Tm+ and 
M1-Tm+ cells are presented for all four subjects. Subject 1 () subject 2 
(), subject 3 (), subject 4 (). The indicated values in graphs (a–d) 
represent a single experiment, while graph (e) combines data of two 
independently repeated experiments.
0
80
60
40
20
NP-Tm M1-Tm
%
 T
NF
-a
+
TN
F-
a
M1-Tm
TN
F-
a
M1-Tm
NP-Tm
NP-Tm
(a) (b)
(c) (d)
18·7% 43·0%
34·6% 52·4%
IL-2lo IL-2hi IL-2lo IL-2hi
IL-2lo
IL-2hi
-----
-----
-----
-----
(e)
100 101 102 103 1041
00
10
1
10
2
10
3
10
4
100 101 102 103 1041
00
10
1
10
2
10
3
10
4
100 101 102 103 1041
00
10
1
10
2
10
3
10
4
100 101 102 103 1041
00
10
1
10
2
10
3
10
4
A. C. M. Boon et al.
50 © 2005 British Society for Immunology, Clinical and Experimental Immunology, 142: 45–52
Also, IL-2 concentration influenced the functional profile of
these polyclonal CTL populations.
Mobilization of CD107a (LAMP-1) and CD107b (LAMP-
2) to the cell surface of CTL has been identified recently as a
marker of degranulation of perforin and granzyme [29], and
therefore as a surrogate marker of target cell lysis. Thus, in
combination with tetramer-staining, CD107a staining allows
the investigation of the cytolytic capacity of polyclonal CTL
populations specific for single epitopes. In addition to
subject-dependent differences in the lytic capacity of CTL,
epitope-dependent differences were also identified in two of
four subjects studied. These differences were profound in
cells cultured in IL-2lo conditions. A fraction of the poly-
clonal Tm+ population did not express CD107a upon stim-
ulation, a phenomenon reported previously by others [32]. It
is unlikely, however, that these CD107a negative cells form a
subset of the polyclonal Tm+ population, with a different
TCR and CDR3 profile [32].
For cytokine expression profiles of the Tm+ cells popula-
tions, subject- and epitope-dependent differences were also
observed (Fig. 5). In particular, NP-Tm+ cells of subject 2
were consistently less functional than the M1-Tm+ cells of
the same subject or NP-Tm+ cells of other subjects. TCR
avidity analysis of NP-Tm+ cells of these four subjects dem-
onstrated that the avidity of NP-Tm+ cells of subject 2 is sig-
nificantly lower than the TCR avidity of the NP-Tm+ cells of
the other three subjects (data not shown). Although a cor-
relation between TCR avidity and the functional profile of
epitope-specific CTL has been described previously [25], it is
of interest that epitope-specific T cell repertoires in subjects
differ regarding their functional avidity. The underlying
mechanism for these differences remains to be elucidated.
Comparison of average frequencies of CD107a, IFN-g and
TNF-a positive cells within the Tm+ cell population (Fig. 5)
showed that the proportion of epitope-specific CTL mobi-
lizing CD107a and producing IFN-g is similar and larger
than the proportion of epitope-specific T cells producing
TNF-a. These data indicate that the hierarchy in effector
CTL function is CD107a = IFN-g > TNF-a, confirming and
extending the previously reported cytokine production hier-
archy of influenza virus-specific CTL [33].
In a previous study it was demonstrated that HLA-A*0101
restricted influenza A virus-specific CTL were more prone to
produce TNF-a than IFN-g, while influenza A virus-specific
CTL restricted by HLA-A*0201 and -B*3501 produced more
IFN-g than TNF-a [23]. In the present study, this was not the
case for the HLA-A*0101 restricted NP-Tm+ cells that pro-
duced mainly IFN-g. CTL responses to other HLA-A1
restricted epitopes may have been responsible for the pre-
dominant TNF-a expression observed previously.
We also noted a significant effect of IL-2 on the function-
ality of polyclonal epitope-specific CTL. High IL-2 concen-
trations during effector cell differentiation resulted in highly
efficient CTL, while effector cell differentiation in IL-2lo con-
ditions resulted in CTL less efficient in mobilizing CD107a
and producing IFN-g and TNF-a. The effect of IL-2 on effec-
tor cell function of CTL has been reported previously for T
cells from humans, monkeys and mice [26,34–38]. In
humans, only CTL clones or T cell lines, passaged multiple
times in vitro, have been studied. Increased IFN-g produc-
tion and lysis by human dengue virus-specific CTL clones
cultured under IL-2hi conditions were observed [37]. Also, it
has been found more recently that IL-2 had a positive effect
on influenza A virus epitope (M158-66)-specific CTL that had
been stimulated three times with peptide-pulsed APC before
their functional properties were investigated [36]. Finally,
addition of exogenous IL-2 following RSV challenge of mice
resulted in increased effector cell function of RSV-specific
CTL [26]. The mechanism of the stimulatory effect of IL-2
on effector cell function is as yet unknown. Recent literature
suggests a role for regulatory T-cells which may inhibit the
effector cell function of CTL, that is inhibited in turn by IL-
2 [39,40]. Increased effector cell function as a result of IL-2
Fig. 5. Functional comparison of NP-Tm+ and M1-Tm+ cells cultured 
under interleukin (IL)-2lo and IL-2hi conditions. The proportion of 
NP-Tm+ (white circles) and M1-Tm+ cells (black squares) mobilizing 
CD107a or expressing interferon (IFN)-g or tumour necrosis factor 
(TNF)-a were plotted against each other for both IL-2lo (a, c, e) and 
IL-2hi conditions (b, d, f). The data were obtained from Figs 2–4.
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was also found for influenza virus stimulated natural killer
(NK)-cells [41], the vital role of which was demonstrated
previously in mice in the induction of an influenza virus-
specific CTL response [42]. Our data also have important
implications for the development of future vaccines, aiming
at the induction of CTL-mediated immunity. These vaccines
should also induce strong IL-2-producing T helper cell
responses, which facilitate the induction of functional
antigen-specific CTL.
Collectively, the data presented here demonstrate that
there is functional heterogeneity among influenza virus-
specific CD8+ T cells. Functional properties of CTL depend
on the epitope that is recognized, but also Tm+ cell popula-
tions displayed functional differences depending on the
subject from which they were obtained. In addition, the con-
centration of IL-2 used during expansion or virus-specific T
lymphocytes has a major influence on the functionality of
these cells. These variables should be taken into account
when interpreting CTL responses induced after infection of
vaccination.
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